Hyperthermic regional perfusion for melanoma and sarcoma of the limbs.
Fraker
D L
DL
University of Pennsylvania, Philadelphia, USA.
D000671:Amputation, Surgical; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000493:pharmacokinetics; D001132:Arm; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000601:surgery; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000009:adverse effects / Q000379:methods*; D003131:Combined Modality Therapy; D006801:Humans; D006979:Hyperthermia, Induced / Q000009:adverse effects / Q000379:methods*; D007866:Leg; D008545:Melanoma / Q000188:drug therapy* / Q000601:surgery; D008558:Melphalan / Q000008:administration & dosage / Q000493:pharmacokinetics; D012509:Sarcoma / Q000188:drug therapy* / Q000601:surgery; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000601:surgery; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage
D018906:Antineoplastic Agents, Alkylating; D014409:Tumor Necrosis Factor-alpha; D008558:Melphalan